entertainment -WSS

entertainment

author：leisure time 2025-08-19 20:44:50 - browse：35157

Illustration of a hospital with stacks of dollar bills on top – private equity coverage from STAT — Adobe

Private equity firms are rapidly buying their way into the U.S. health care system, and as they do, new research finds they tend to increase costs and may also harm quality.

A new BMJ systematic review rounded up 55 studies on the effects of private equity buyouts in health care globally to flesh out an overarching conclusion. The team of researchers found that private equity ownership generally means higher costs for patients, insurance companies, and government programs. The effects on quality were mixed, with more evidence showing that such financial investors degrade quality.

“This is really the first widespread snapshot of what the impacts of all these developments are,” said Alexander Borsa, a study author and doctoral candidate at Columbia University.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The high cost of giving birth even with insurance
Next article： Three trends to watch in biotech in 2024

hotspot

WSS

David Ricks of Eli Lilly: best biopharma CEO of 2023

UnitedHealth financials solid despite Change Healthcare cyberattack

BIO: Crackdown on China pharma industry would threaten U.S. drug supply

Readout Newsletter: Novavax stock, FogPharma, Novo Nordisk

SNAP should offer more nutrition education

FTC falls short on scrutinizing hospital mergers, study says

entertainment

entertainment

hotspot

Hepatitis C has a cure — but many Americans still lack access to it

Cancer researcher Catriona Jamieson is sending tumors into space

ChatGPT in medicine: STAT answers readers' burning questions

Editas, Vertex strike deal on CRISPR

Apple is now the first public company to be valued at $3 trillion

How to keep neuroscience’s past racism from being its future

Novavax promises a turnaround & Lilly roils the obesity market

Violet CEO on training clinicians to promote more inclusive care

Heart attack and stroke risk calculators need revising

Medicare drug price negotiation hasn't dried up venture capital

focus

Close Medicare's dangerous gaps in addiction treatment coverage

Bristol Myers buys into radiopharmaceuticals with RayzeBio

UnitedHealth financials solid despite Change Healthcare cyberattack

Readout Newsletter: Novavax stock, FogPharma, Novo Nordisk

MultiPlan and major insurers sued for alleged medical price

Carvykti CAR

hotspot

hotspot

explore

entertainment